Grapevine: PEs eye India's largest cardiac stent maker; O2 Power race heats up

Premium

Private equity firms KKR, TPG Capital and Apax Partners are evaluating India's largest cardiac stent maker Sahajanand Medical Technologies (SMT), valuing the company at Rs 3,500-4,000 crore, a media report said.     One more global private equity firm and Mumbai-based pharmaceutical firm Alkem Laboratories are also in the fray, The Economic Times reported, citing people familiar with ......